Zimmer Biomet Holdings, Inc. P/E Ratio 2007–2025
Zimmer Biomet Holdings, Inc. reported 25.19 of price-to-earnings ratio for fiscal 2025. That was 7.3% higher than fiscal 2024. Compared with fiscal 2019, the change was -2.8%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 25.19 | +7.3% |
| FY 2024 | 23.48 | -3.6% |
| FY 2023 | 24.35 | -78.3% |
| FY 2022 | 112.32 | +75.7% |
| FY 2021 | 63.92 | — |
| FY 2020 | — | — |
| FY 2019 | 25.92 | — |
| FY 2018 | — | — |
| FY 2017 | 12.64 | -79.4% |
| FY 2016 | 61.37 | -48.3% |
| FY 2015 | 118.62 | +383.0% |
| FY 2014 | 24.56 | +32.7% |
| FY 2013 | 18.51 | +37.4% |
| FY 2012 | 13.47 | +18.5% |
| FY 2011 | 11.36 | -26.7% |
| FY 2010 | 15.49 | -1.4% |
| FY 2009 | 15.72 | +63.9% |
| FY 2008 | 9.59 | -44.8% |
| FY 2007 | 17.39 | — |
Source: Zimmer Biomet Holdings, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ZBH 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Zimmer Biomet Holdings, Inc. reported 25.19 of price-to-earnings ratio for fiscal 2025. That was 7.3% higher than fiscal 2024. Compared with fiscal 2019, the change was -2.8%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Zimmer Biomet Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeZimmer Biomet Holdings, Inc. — frequently asked questions
What is Zimmer Biomet Holdings, Inc.'s price-to-earnings ratio?
Zimmer Biomet Holdings, Inc. (ZBH) reported price-to-earnings ratio of 25.19 for fiscal year 2025, per its SEC filings.
How has Zimmer Biomet Holdings, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, ZBH's price-to-earnings ratio grew at roughly 2.1% per year (compound annual rate), from 17.39 to 25.19.
Where does this data come from?
Figures are computed from Zimmer Biomet Holdings, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More ZBH financial history
Full ZBH fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →